Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1976-07-16
1977-06-14
Coughlan, Jr., Paul M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
260268BC, A61K 31495, C07D29500
Patent
active
040297888
ABSTRACT:
This disclosure describes compounds of the class of 5- or 6-substituted 2,3-bis(4-alkyl-1-piperazinyl)quinoxalines useful for ameliorating cecal and hepatic amebic infestations in warm-blooded animals.
REFERENCES:
sen et al., J. Indian Chem. Soc., vol. 38 (1961), pp. 225-228.
Fabio Paul Frank
Lang, Jr. Stanley Albert
Lin Yang-I
Tomcufcik Andrew Stephen
American Cyanamid Company
Conroy, Jr. Edward A.
Coughlan, Jr. Paul M.
LandOfFree
2,3-Bis(4-alkyl-1-piperazinyl)quinoxalines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,3-Bis(4-alkyl-1-piperazinyl)quinoxalines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,3-Bis(4-alkyl-1-piperazinyl)quinoxalines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-10804